(Q42437787)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

José Sereno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Maria J Pereira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alice Melão

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Eugénia Carvalho

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

P Lopes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Fuhrmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

P Nunes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Pedro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

1 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1142-1148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23622647%20AND%20SRC:MED&resulttype=core&format=json

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Current immunosuppressive agents: efficacy, side effects, and utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Sirolimus: a new option in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Dissecting the role of mTOR: lessons from mTOR inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

TOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Sirolimus for calcineurin inhibitors in organ transplantation: contra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Dyslipidemia following kidney transplantation: diagnosis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Long-term cyclosporine treatment in non-transplanted rats and metabolic risk factors of vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

The TOR signal transduction cascade controls cellular differentiation in response to nutrients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009

Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.02.009